Obese asthma phenotypes display distinct plasma biomarker profiles

• Published in: Clinical and translational allergy 2023-03, Vol.13 (3), p.e12238-n/a
• Main Authors: Björkander, Sophia, Klevebro, Susanna, Hernandez‐Pacheco, Natalia, Kere, Maura, Ekström, Sandra, Sparreman Mikus, Maria, Hage, Marianne, James, Anna, Kull, Inger, Bergström, Anna, Mjösberg, Jenny, Tibbitt, Christopher Andrew, Melén, Erik
• Format: Article
• Language: English
• Subjects: Allergens; Allergies; Asthma; Biomarkers; Body fat; Body mass index; Eczema; Homeostasis; Inflammation; Medicin och hälsovetenskap; Obesity; Original; Overweight; Plasma; plasma biomarker; Proteins; Questionnaires; Regression analysis; Rhinitis; Spirometry
• ISSN: 2045-7022; 2045-7022
• DOI: 10.1002/clt2.12238

Background Obese asthma is a complex phenotype and further characterization of the pathophysiology is needed. This study aimed to explore inflammation‐related plasma biomarkers in lean and overweight/obese asthmatics. Methods We elucidated levels of inflammation‐related plasma proteins in obese asthma phenotypes in the population‐based cohort BAMSE (Swedish: Children, Allergy, Milieu, Stockholm, Epidemiology) using data from 2069 24‐26‐year‐olds. Subjects were divided into lean asthma (n = 166), lean controls (n = 1440), overweight/obese asthma (n = 73) and overweight/obese controls (n = 390). Protein levels (n = 92) were analysed using the Olink Proseek Multiplex Inflammation panel. Results Of the 92 included proteins, 41 were associated with lean and/or overweight/obese asthma. The majority of proteins associated with overweight/obese asthma also associated with overweight/obesity among non‐asthmatics. Beta‐nerve growth factor (BetaNGF), interleukin 10 (IL‐10), and matrix metalloproteinase 10 (MMP10) were associated only with lean asthma while C‐C motif chemokine 20 (CCL20), fibroblast growth factor 19 (FGF19), interleukin 5 (IL‐5), leukemia inhibitory factor (LIF), tumor necrosis factor ligand superfamily member 9 (TNFRSF9), and urokinase‐type plasminogen activator (uPA) were associated only with overweight/obese asthma. Overweight/obesity modified the association between asthma and 3 of the proteins: fibroblast growth factor 21 (FGF21), interleukin 4 (IL‐4), and urokinase‐type plasminogen activator (uPA). In the overweight/obese group, interleukin‐6 (IL‐6) was associated with non‐allergic asthma but not allergic asthma. Conclusion These data indicate distinct plasma protein phenotypes in lean and overweight/obese asthmatics which, in turn, can impact upon therapeutic approaches.